Vanguard CPV Suspensie voor injectie
Vanguard CPV Suspensie voor injectie
Authorised
- Canine parvovirus, strain NL-35-D, Live
Product identification
Medicine name:
Vanguard CPV Suspensie voor injectie
Vanguard CPV Suspension injectable
Vanguard CPV Injektionslösung
Active substance:
- Canine parvovirus, strain NL-35-D, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parvovirus, strain NL-35-D, Live10000000.00/cell culture infective dose 501.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Vanguard CPV 100 Vials with 1 dose of Suspension for injection
- Vanguard CPV 25 Vials with 1 dose of Suspension for injection
- Vanguard CPV 10 Vials with 1 dose of Suspension for injection
- Vanguard CPV 1 Vial with 1 dose of Suspension for injection
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium SA
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V161576
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
How useful was this page?:
